Cargando…
EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis
PRDM1/Blimp1, a master regulator of B-cell terminal differentiation, has been identified as a tumor suppressor gene in aggressive lymphomas, including diffuse large B-cell lymphoma (DLBCL). It has been shown in DLBCL and Hodgkin lymphoma that PRDM1 is downregulated by cellular microRNAs. In this stu...
Autores principales: | Ma, J, Nie, K, Redmond, D, Liu, Y, Elemento, O, Knowles, D M, Tam, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777778/ https://www.ncbi.nlm.nih.gov/pubmed/26530011 http://dx.doi.org/10.1038/leu.2015.285 |
Ejemplares similares
-
Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma
por: Zhang, T, et al.
Publicado: (2014) -
EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023) -
EBV-miR-BHRF1-1 Targets p53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia
por: Xu, Dan-Min, et al.
Publicado: (2020) -
Genetic variability and mutation of Epstein‒Barr virus (EBV)-encoded LMP-1 and BHRF-1 genes in EBV-infected patients: identification of precise targets for development of personalized EBV vaccines
por: Wang, Yue, et al.
Publicado: (2023) -
Essential role of hyperacetylated microtubules in innate immunity escape orchestrated by the EBV-encoded BHRF1 protein
por: Glon, Damien, et al.
Publicado: (2022)